StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Revenues

<< Previous

Bullboard Posts

Next >>

Comment by frewil11on Jan 25, 2021 10:03am

137 Views

Post# 32374348

RE:RE:RE:Revenues

I watched the video and it looks like Stage Zero is going to count on the mobile phlebotomists a great deal because Tripp did mention that there is a lot of problems with trying to go the route with health care insurance companies like Blue Cross for example he said , I was hoping that it was going to be part of your health care plan and paid for through it .

<< Previous

Bullboard Posts

Next >>

Unique Battery Metals opportunity in Quebec